Cipher Pharma (CPHR) Misses Q3 EPS by 1c

Cipher Pharma (NASDAQ: CPHR) reported Q3 EPS of ($0.08), $0.01 worse than the analyst estimate of ($0.07). Revenue for the quarter came in at $9.3 million versus the consensus estimate of $10.42 million.

For earnings history and earnings-related data on Cipher Pharma (CPHR) click here.

You May Also Be Interested In

• Amphenol (APH) Tops Q1 EPS by 7c, offers guidance
• Ribbon Communications (RBBN) Misses Q1 EPS by 2c; offers guidance
• Hasbro (HAS) brand strength sees earnings top expectations